MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

Wound Healing Society (WHS) Symposium on Advanced Wound Care (SAWC) "These new data further validate EscharEx's unique mechanism of action and its potential to redefine the standard of care for chronic wound management," said Dr. Robert Snyder, Chief Medical Officer at MediWound. "We remain committed to advancing EscharEx through rigorous clinical development, with the goal of offering a meaningful, non-surgical solution for patients suffering from chronic wounds." Presentations at WHS and SAWC to highlight ...